But
if preclinical research continues positively, there may be a surprising potential source of GM1: the brains of sheep.
Not exact matches
«Improving the design, conduct, and reporting of
preclinical research is of the utmost priority
if we are to move ahead, with all due haste, in the development of novel treatments across a range of diseases.»
If too few MDs go into
preclinical research, this field will lose valuable input, many believe.
He further notes that there is ``... significant discordance between
preclinical findings and clinical results» and ``... inefficient partnerships between academia and industry,» two challenges that must be addressed
if academic
research is to yield maximum clinical benefit and attain the ultimate goal of saving patients» lives.